Researchers in Prof. Mark Kay's laboratory have developed recombinant adeno-associated viral (AAV) capsid proteins that transduce human primary hepatocytes at high efficiency in vitro and in vivo.
Robots will need sensory skins to safely interact with humans and navigate more complex environments than factory work cells. This invention is a new stretchable pneumatic sensor skin that can feel its surroundings and reach for objects in constrained environments.
Engineers in Prof. Mark Cutkosky's laboratory have developed a gentle gripper device that can conform to, grasp, and lift a wide range of objects using an air bladder enhanced with gecko-inspired shear adhesion.
Researchers in Prof. Mark Kay's laboratory have continued to develop novel recombinant adeno-associated viral (AAV) capsids via capsid gene shuffling that transduce human hepatocytes at high efficiency in vivo.
Stanford researchers have developed a high efficiency OLED device by nanopatterning the electrode layer to create a high impedance metasurface (HIM) that reduces 'plasmonic' losses. A typical metal cathode traps a large portion of generated light in an OLED.
Researchers in Prof. Mark Cutkosky's laboratory have developed gloves with customized patterns of sticky (dry adhesive) and non-sticky areas to assist the wearer with lifting and handling smooth heavy objects, particular those with a tacky coating.
Stanford researchers have developed an optical coating that steers infrared and visual light in different paths while suppressing the typical undesired rainbow effect.
Stanford researchers at the Woo Lab have invented a composite inclusion graft that addresses several challenges associated with the Ross procedure, such as late autograft dilation.
Stanford researchers have invented a twist-expand mechanical bioreactor that provides an appropriate in vitro microenvironment for induced pluripotent stem cell (iPSC) derived cardiomyocytes to achieve biomimetic anisotropic alignment and form contractile cardiac tissue
Stanford researchers have discovered that Neat1, a long non-coding RNA, regulates degradation of the MYC protein, revealing a new target for treating MYC-dependent cancers.
Researchers in Dr. Mark Kay's laboratory at Stanford University have designed a new liver-specific expression cassette for inserting genes into double-stranded AAV (adeno-associated virus) vectors for gene therapy.
Researchers in Dr. Mark Kay's lab have developed a patented approach to inducing apoptosis that could represent a new strategy against cancer and other diseases.
Stanford researchers developed a single plasmid reprogramming system called CoMiP carrying codon optimized sequences of the canonical reprogramming factors (OKSM) and short hairpin RNA against p53.